Unlocking the human genetics of COVID
Medium |
July 2021
G2P Blog
In an unprecedented international effort, researchers and clinicians tackle the genomics of COVID-19 risk.
G2P Blog
Precision medicine: From breakthrough to follow-through
Medium |
May 2021
G2P Blog
Nic Encina, Director of Strategy of the Precision Population Health (PPH) Initiative at Ariadne Labs, describes the recent launch of PPH into the world of precision medicine. “We feel that Genomes2People’s real-world research in genomic return-of-results combined with Ariadne Labs’ practical approach to health system innovation and implementation are aptly suited for tackling implementation obstacles … Continued
Genomic literacy in high school: Building the future
Medium |
April 2021
G2P Blog
In this blog post, G2P trainee Sachi Badola speaks to the importance of genetic literacy and proposes a genetics elective to be offered to all high school students that comprehensively covers the implications, limitations, and challenges of genomic medicine and precision health in the future.
A pharmacist’s journey into genomic medicine
Medium |
February 2021
G2P Blog
Former G2P trainee Cathelijne van der Wouden, PharmD, shares about her journey into genomic medicine as a pharmacist-in-training in this G2P blog post.
Race, ancestry, and representation: The role of genetic medicine
Medium |
September 2020
G2P Blog
Race is a social construct, but representation matters in genetic studies — and on that front, we have a long way to go. By Tala Berro, MS, CGC
Genetic counselors and the fight for medicare recognition
Medium |
May 2020
G2P Blog
Elizabeth Fieg, MS, LCGC discusses the importance and implication of the H.R. 3235-The Access to Genetic Counselor Service Act that would authorize and recognize appropriately credentialed genetic counselors as reimbursable providers under Medicare.
Econogenomics: The economics of genomic testing for health
Medium |
January 2020
G2P Blog
“The cost of sequencing itself is already comparable to a lot of other diagnostic tests regularly used in medicine,” Kurt Christensen, PhD said. Besides: “What really moves the needle on cost effectiveness isn’t the costs — it’s the benefits.”
Is preventive genomics elitist?
Medium |
October 2019
G2P Blog
The ultimate aim of our Genomes2People Research Program is to contribute to the transformation of medicine from reactive to proactive, from treatment-oriented to preventive. We are trying to help build the evidence base that will justify societal decision to make these technologies and services accessible to anyone who wants them, regardless of means, education or … Continued
How frequently should genomic results be updated?
Medium |
June 2019
G2P Blog
Continuous new discoveries about the genome make updates important.
Sharing, caring, and the complications of sequencing a baby’s genome
Medium |
May 2019
G2P Blog
When a newborn’s genome is sequenced, should some results be withheld?
Guest post: We can do better – The experience of a minority genetic counselor
DNA Exchange |
April 2019
G2P Blog
Tala Berro, MS, LCGC writes about her experiences as a minority genetic counselor during her training and clinical rotations. Berro shares, “To my fellow genetic counselors, I propose the following version of the golden rule: treat your peers as you treat your patients”.
Is it too soon to consider genome sequencing for newborns?
Medium |
March 2019
G2P Blog
Parents and clinicians have their own ideas about newborn genome sequencing. Dr. Robert Green, principal investigator of the BabySeq Project, shares a detailed analysis of the results from the study and his thoughts on the utility of genomic sequencing for newborns in clinical care.
Studying personal genomics: Expanding the pool
Medium |
November 2018
G2P Blog
While a good deal of research has focused on finding information within the human genome that can diagnose rare conditions, far less work has been done to understand the longer-term consequences of identifying genetic risks in apparently healthy people. Read more the PeopleSeq Consoritum from the principal investigator, Dr. Robert Green!
Decoding FDA DTC policy
SOUNDROCKET |
November 2018
G2P Blog
Scott D. Crawford, Shawn Fayer, and Robert C. Green directly address and highlight some of the recent FDA movement in the direct-to-consumer (DTC) genetic testing space with a five-post blog compilation.
The true cost of whole genome sequencing
Medium |
September 2018
G2P Blog
The true costs of genome sequencing don’t end with the technical production of A’s, T’s, C’s and G’s, and they don’t even end with the molecular interpretation of a few dozen or even a few hundred genes.
Genomic sequencing for newborns: Are parents receptive?
Boston Children's Hospital |
September 2018
G2P Blog
Casie Genetti, MS, CGC, a licensed genetic counselor with the Manton Center for Orphan Disease Research at Boston Children’s Hospital is first author of a recently published paper on the BabySeq Project and author of this blog about parents’ receptiveness to genome sequencing.
Genome sequencing for healthy people: Will it be harmful?
Medium |
March 2018
G2P Blog
The second piece of a 2-part blog series authored by Dr. Robert C. Green. An early study found no problems related to unnecessary or harmful medical follow-ups after healthy people received their genome sequencing results. To read the first piece, visit: https://medium.com/@genomes2people/genome-sequencing-for-healthy-people-will-it-be-helpful-b984b94e3d3f
Genome sequencing for healthy people: Will it be helpful?
Medium |
February 2018
G2P Blog
The first piece of a 2-part blog series authored by Dr. Robert C. Green. Early results suggest that yes, whole genome sequencing may very well be substantially helpful to a significant number of healthy patients. To read the second piece, visit: https://medium.com/@genomes2people/genome-sequencing-for-healthy-people-will-it-be-harmful-d915cc08e634
Genetic privacy concerns are on the rise for families and researchers
Huffington Post |
June 2017
G2P Blog
Dr. Robert Green discusses genetic privacy concerns and questions about whole genome sequencing that have arisen from parents whose children are participating in the BabySeq project.
You didn’t ask for these genomic test results, but they might save your life
Huffington Post |
April 2017
G2P Blog
We found that almost exactly 1% of the populations in both FHS and JHS carried a pathogenic variant in one of the original ACMG56 genes. And we found that those carrying pathogenic variants had an increased aggregated risk of developing clinical features associated with the corresponding diseases.
Genome for healthy people: Early results
Huffington Post |
January 2017
G2P Blog
This is part of our overall scientific mission to determine how personal genomic sequencing may impact participants’ long-term health, behavioral and economic outcomes.
Genetic risk, smoking behavior and the question of false reassurance
Huffington Post |
November 2016
G2P Blog
Many patients succumb to the idea of “false reassurance.” Dr. Robert Green addresses these assumptions in relation to smoking behavior.
Genome sequencing for healthy people: Is it time?
The Huffington Post |
September 2016
G2P Blog
A blog post authored by Dr. Robert Green discussing the benefits and challenges that people and health professionals are faced with when dealing with genetic testing and screening. Here, he addresses ethical issues and potential complications alongside beneficial factors that deal genome testing.
Should researchers share genomic results with participants’ relatives?
Huffington Post |
May 2016
G2P Blog
“When researchers discover something about a participant that could significantly affect that person’s relatives, do the researchers have a duty to tell the relatives? Are the researchers bound to protect the participant’s privacy even if the participant is deceased?”
What about personal genomic testing if you are adopted?
Huffington Post |
March 2016
G2P Blog
Genomes2Peoples study on personal genetic testing proved to be very beneficial for adoptees that were curious about their family genetic history.
Exponential Medicine conference and the “Last Mile” problem in genomic medicine
Huffington Post |
March 2016
G2P Blog
The big question is how to make genomic information useful to patients and medical practitioners; Genomes2People is looking for answers through the MedSeq and BabySeq projects, among others.
Motivations for personalized genetic testing include explaining – not just predicting
Huffington Post |
January 2016
G2P Blog
A blog post written by Robert Green addresses why people are motivated for continued with personalized genetic testing. “Our study suggested that the motivations for this interest go beyond simply predicting risk… and that for these participants, their fascination with genetics was an attempt to understand the condition that they had,” he says.
Genomic sequencing: Just another tool in the doctor’s bag
Huffington Post |
December 2015
G2P Blog
Dr. Robert Green digs deeper into his one of his own projects, MedSeq. He explains the motivation behind the project, his hopes for what will be achieved, and how this study will lead to helping other doctors understand how genomics will help their patients individually.
Genomic testing makes consumers less confident in understanding genetics (and that’s probably okay)
Huffington Post |
October 2015
G2P Blog
How well do people who receive genomic information from direct-to-consumer testing, such as 23andMe, understand their results? The Impact of Personal Genetic Study (PGen) asked consumers to report on their experience.
ACMG recommendations are a controversial but necessary step towards genomic medicine
Huffington Post |
May 2013
G2P Blog
Dr. Robert Green responds to criticism of the American College of Medical Genetics (ACMG) recommendations on incidental findings in clinical sequencing, and explains the need for these recommendations.
